Patent application number | Description | Published |
20080319793 | Method and commuication system for supporting the adherence to the study protocol of a clinical study - In at least one embodiment of a method for supporting a person involved in a clinical study in the adherence to a study protocol, an automatic communication system is disclosed which collects data correlated with the performance of the study in at least approximately real time from a data processing system concerned with the study, determines, by use of the data, a first future time for a study action to be performed according to the study protocol, and, by use of a planning criterion, a second future time which is before the first one. In at least one embodiment, the communication system, at the second time, sends a message concerning the study action to the person. A corresponding communication system contains, in at least one embodiment, an interface for collecting the data, a control and evaluating unit for determining the first and second time, and a communication interface for sending the message. | 12-25-2008 |
20090112619 | Pay For Studies Submitted (PASS) Method For Clinical Trials - A system and method is disclosed for facilitating the acquisition of medical images used as part of a clinical trials process by requiring Imaging Centers to compete with each other to supply the images. Agreements between the Sponsor and a plurality of Imaging Centers stipulate that the Sponsor is only required to accept a certain total number of medical images and is free to reject any medical images that either do not comply with the protocol, or which exceed the total number of medical images required for the study. This motivates the Imaging Centers to quickly obtain and transmit to the Sponsor high quality medical images that meet the basic requirements outlined in the clinical study protocol, since images are accepted and compensated for by the Sponsor on a first-come, first-served basis. A system for implementing this method is also disclosed. | 04-30-2009 |
20100174505 | Conditioned medical testing - The invention refers to a computer implemented method, a computer system a test machine and a computer program product for executing conditioned and qualified test. An ordering instance may order a set of tests, comprising an initial test and a set of follow-up tests, wherein the execution of each of the follow-up tests is dependent of the result of the respective predecessor test, like the initial test. The conditions for executing the follow-up tests are dynamically definable and are analyzed automatically. | 07-08-2010 |
20100174555 | System for automatic clinical pathway optimization - At least one embodiment of the present invention refers to a method, a system, a computer readable medium and/or a computer program product for optimizing a clinical pathway. The clinical pathway includes a sequence of actions. In at least one embodiment, he method aims at finding the best suitable and optimal following action for a respective action. There is provided a set of rules, patient information data and optimization criteria. After having received a symptom or an action there is deduced a set of possible following actions. After having deduced all possible following actions, these possible following actions are evaluated by the optimization criteria. After evaluation the optimal following action is suggested as a result. | 07-08-2010 |
20100331673 | SYSTEM AND METHOD FOR REDUCING PATIENT RISK OF ALLERGIC REACTION TO CONTRAST AGENTS OR MEDICAL MATERIAL - A system and method for improving safety in medical procedures where a substance is introduced into a patient is described. An in-vitro diagnostic (IVD) device may be used to measure the concentration of an analyte representing a marker and compare the measured concentration with a predetermined set point so as to determine whether an adverse reaction to the substance may be anticipated. The test data may be obtained at the point-of-service or retrieved from a patient data base. The device for administering the substance is enabled when the comparison of the test data with the predetermined set point indicates that the procedure is expected to be performed with an acceptable risk of an adverse reaction. | 12-30-2010 |
20100331833 | IN-VITRO DEVICE MONITORING DURING MINIMALLY INVASIVE ABLATION THERAPY - A method and apparatus for monitoring and controlling interventional therapy is described, where the interventional therapy results in the destruction of tissue and the release of chemical markers. When interventional therapy results in destruction of a patient tissue, such as cancerous tissue, a variety of chemical markers may be released into the bloodstream. An in-vitro diagnostic (IVD) device may be used to measure the concentration of an analyte representing a marker and compare the measured concentration with a predetermined set point so as to monitor or control the procedure. The blood for the analysis may be obtained either inter-procedurally or intra-procedurally depending on the promptness of the effect being measured and the speed of measurement. | 12-30-2010 |
20100332254 | IN-VITRO DEVICE SUPPORT FOR X-RAY BASED KIDNEY FUNCTION TEST - A system and method of diagnosing kidney syndromes using an intravenous pyelogram (IVP) is described. The system includes an X-ray imaging device and an in-vitro diagnostic (IVD) device. The IVD device is used to identify risk factors such as sensitivity to contrast agents, or to indicate or rule out other syndromes which may have symptoms similar to kidney malfunction. The level of blood components such as creatinine may be used, in conjunction with other medical data and IVD tests, to determine a risk score for the patient. The risk score may be used to recommend modifications to a baseline procedure such as change in the volume or type of contrast agent, the number of X-rays, or the performance of post-procedure dialysis. | 12-30-2010 |
20130253944 | METHOD AND SYSTEM FOR MEASURING QUALITY OF PERFORMANCE AND/OR COMPLIANCE WITH PROTOCOL OF A CLINICAL STUDY - A method is proposed for determining clinical study compliance. The method includes obtaining criteria for the clinical study and accessing stored clinical data relating to the clinical study. Thereafter, the criteria and clinical data are correlated to determine a measure of compliance with the criteria of the clinical study. | 09-26-2013 |
20130253945 | METHOD AND SYSTEM FOR MEASURING QUALITY OF PERFORMANCE AND/OR COMPLIANCE WITH PROTOCOL OF A CLINICAL STUDY - A method is proposed for determining clinical study compliance. The method includes obtaining criteria for the clinical study and accessing stored clinical data relating to the clinical study. Thereafter, the criteria and clinical data are correlated to determine a measure of compliance with the criteria of the clinical study. | 09-26-2013 |